1. Home
  2. ADNT vs PRCT Comparison

ADNT vs PRCT Comparison

Compare ADNT & PRCT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Adient plc

ADNT

Adient plc

N/A

Current Price

$17.77

Market Cap

1.4B

ML Signal

N/A

Logo PROCEPT BioRobotics Corporation

PRCT

PROCEPT BioRobotics Corporation

N/A

Current Price

$16.86

Market Cap

1.2B

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
ADNT
PRCT
Founded
2016
2009
Country
Ireland
United States
Employees
N/A
N/A
Industry
Auto Parts:O.E.M.
Medical Specialities
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.4B
1.2B
IPO Year
2016
2021

Fundamental Metrics

Financial Performance
Metric
ADNT
PRCT
Price
$17.77
$16.86
Analyst Decision
Buy
Hold
Analyst Count
12
14
Target Price
★ $29.55
$21.64
AVG Volume (30 Days)
764.3K
★ 1.2M
Earning Date
11-04-2026
11-03-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ 1.71
EPS
★ 0.38
N/A
Revenue
★ $17,439,000,000.00
$308,054,000.00
Revenue This Year
$3.41
$28.36
Revenue Next Year
$0.49
$20.60
P/E Ratio
$45.42
★ N/A
Revenue Growth
7.56
★ 37.22
52 Week Low
$16.72
$16.67
52 Week High
$27.32
$38.11

Technical Indicators

Market Signals
Indicator
ADNT
PRCT
Relative Strength Index (RSI) 36.91 43.29
Support Level N/A $16.89
Resistance Level $22.52 $29.12
Average True Range (ATR) 0.71 0.86
MACD -0.12 -0.09
Stochastic Oscillator 0.00 34.47

Price Performance

Historical Comparison
ADNT
PRCT

About ADNT Adient plc

Adient began trading in October 2016, when Johnson Controls spun off its automotive experience segment. Adient is a leading seating supplier to the industry with about a midteens share of the global market, including unconsolidated joint venture business. Its share in China is around 20%, down from about 45% following the sale of its main joint venture there at the end of fiscal 2021. Unconsolidated revenue from joint ventures was about $3.5 billion in fiscal 2025, and consolidated China revenue was $1.3 billion. The company is headquartered in Ireland but has corporate offices in the Detroit area. Fiscal 2025 (ended September) consolidated revenue, which excludes joint venture sales, was $14.5 billion.

About PRCT PROCEPT BioRobotics Corporation

PROCEPT BioRobotics Corp is a surgical robotics company focused on advancing patient care by developing transformative solutions in urology. The company develops, manufactures, and sells the AquaBeam Robotic System and HYDROS Robotic System, image-guided, surgical robotic systems for use in minimally invasive urologic surgery, with an initial focus on treating benign prostatic hyperplasia, or BPH. Geographically, the company generates a majority of its revenue from the United States and also has a presence in markets outside the U.S.

Share on Social Networks: